The difference between a productive microdosing practice and a frustrating one often comes down to something most people overlook: the schedule. You can nail the perfect dose, source high-quality substances, and set clear intentions, but if your protocol doesn’t match your lifestyle and neurochemistry, you’re working against yourself. After spending years observing how different people respond to various microdosing schedules, including the Stamets stack, Fadiman protocol, and intuitive approaches, one thing has become crystal clear: there’s no universal “best” schedule, only the best schedule for you.
The concept of sub-perceptual dosing sits at the heart of every legitimate microdosing protocol. You’re not trying to feel high. You’re not chasing visual distortions or altered states. Instead, you’re introducing just enough of a psychoactive compound to influence neuroplasticity, mood regulation, and cognitive flexibility without disrupting your ability to work, drive, or navigate daily responsibilities. This threshold varies significantly between individuals, which is why understanding the fundamentals matters before committing to any specific schedule.
What makes microdosing schedules particularly interesting is how they account for tolerance, integration, and the cumulative effects of repeated low-dose exposure. Each protocol represents a different theory about how the brain responds to these substances over time, and each has passionate advocates who swear by their approach.
A microdose typically falls between 5% and 10% of what would be considered a full psychedelic dose. For psilocybin mushrooms, this translates to roughly 0.05 to 0.3 grams of dried material, though individual sensitivity can push this range in either direction. LSD microdoses generally fall between 5 and 20 micrograms, a fraction of the 100 to 200 microgram doses associated with full psychedelic experiences.
The “sub-perceptual” qualifier is crucial here. If you’re noticing significant perceptual changes, feeling noticeably different in ways that would be obvious to others, or experiencing anything resembling a “come up,” you’ve exceeded the microdose threshold. This isn’t necessarily dangerous, but it defeats the purpose of the practice and makes it difficult to maintain a consistent schedule alongside normal life.
Finding your personal threshold requires some experimentation. Most practitioners recommend starting at the lower end of the range and gradually increasing until you find the sweet spot where you notice subtle benefits without overt psychoactive effects. Some people are highly sensitive and find that 0.05 grams of psilocybin is plenty. Others need 0.25 grams to notice anything at all. Genetic variations in liver enzymes, body weight, individual neurochemistry, and even gut microbiome composition all play roles in this variation.
The quality and potency of your material matters enormously. Psilocybin content in mushrooms varies wildly depending on species, growing conditions, and which part of the mushroom you’re consuming. Caps typically contain higher concentrations than stems. Freshly dried material tends to be more potent than older stock. This variability is one reason why many experienced microdosers prefer to grind their material into a fine powder and homogenize it before measuring doses, ensuring consistency across their supply.
Psychedelics build tolerance rapidly, far faster than most other psychoactive substances. If you took a full dose of psilocybin today and tried to repeat the experience tomorrow, you’d need roughly double the amount to achieve similar effects. This tolerance develops at the receptor level, specifically the 5-HT2A serotonin receptors that mediate most of psilocybin’s effects.
Rest days serve multiple purposes in microdosing protocols. They prevent tolerance buildup that would require escalating doses to maintain effects. They provide contrast that helps you notice the subtle differences between dosing and non-dosing days. And they give your brain time to integrate any neuroplastic changes that occurred during the dosing period.
The standard advice suggests that tolerance returns to baseline within about 10 to 14 days of abstinence from psychedelics. However, at microdose levels, the tolerance picture becomes more nuanced. Some researchers and practitioners believe that the sub-perceptual nature of microdoses may produce less dramatic tolerance effects, though this remains an area of ongoing investigation.
Beyond tolerance, rest days matter for psychological integration. Even subtle shifts in perception, mood, or cognition benefit from periods of normal baseline functioning. These off days allow you to observe whether benefits persist beyond the acute dosing window and help you distinguish between direct substance effects and lasting changes in your default state.
Dr. James Fadiman’s research on microdosing, beginning in the early 2010s, produced what has become the most widely adopted schedule for newcomers. His protocol emerged from collecting reports from thousands of self-experimenters and identifying patterns in what worked reliably across diverse populations. The simplicity of his approach is intentional: it’s designed to be easy to follow while providing clear data about how microdosing affects you specifically.
Fadiman’s work emphasized the importance of systematic self-observation. He didn’t just want people to microdose; he wanted them to track their experiences carefully enough to draw meaningful conclusions. This scientific mindset, applied to personal experimentation, distinguishes serious microdosing practice from casual substance use.
The protocol’s conservative nature makes it particularly suitable for people with demanding jobs, family responsibilities, or health concerns that require predictability. You always know which days you’ll be dosing, and the generous rest periods minimize the risk of tolerance issues or cumulative effects that might interfere with your baseline functioning.
The Fadiman protocol follows a straightforward rhythm: dose on day one, rest on days two and three, then repeat. This creates a cycle where you’re dosing roughly every third day, or about twice per week. Most practitioners dose in the morning, allowing the subtle effects to unfold throughout the day without interfering with sleep.
A typical month following this protocol might look like dosing on days 1, 4, 7, 10, 13, 16, 19, 22, 25, and 28. The specific days matter less than maintaining the consistent spacing. Some people prefer to start their cycles on particular days of the week to create a predictable rhythm that fits their schedule.
Fadiman recommends following this protocol for at least one month, ideally two, before drawing conclusions about whether microdosing works for you. This timeframe allows you to experience enough dosing days to identify patterns while accounting for the natural variability in daily mood and energy that everyone experiences.
The two rest days between doses serve the tolerance management function discussed earlier, but they also create space for what Fadiman calls the “afterglow” effect. Many people report that the benefits of a microdose extend beyond the dosing day itself, with day two often feeling particularly positive even without additional substance.
The second day in the Fadiman cycle, the first rest day following a dose, often receives special attention from practitioners. This “afterglow” period is when many people report the most noticeable benefits: improved mood, enhanced creativity, easier social interactions, and a general sense of well-being that feels more stable than the dosing day itself.
The afterglow phenomenon suggests that microdosing’s benefits may work partially through mechanisms that extend beyond the immediate presence of the substance in your system. Psilocybin is metabolized relatively quickly, with most of it cleared from the body within 24 hours. Yet the subjective effects often persist longer, possibly reflecting neuroplastic changes or shifts in neural connectivity patterns that outlast the chemical itself.
Tracking your experience across all three days of the cycle provides valuable data. Many practitioners use simple rating scales, scoring their mood, energy, focus, anxiety, and creativity on a 1 to 10 scale each day. Over time, patterns emerge that reveal how you specifically respond to the protocol.
Some questions worth tracking: Do you feel better on dosing days or afterglow days? Does the third day feel like a return to baseline, or do benefits persist? Are there any negative effects that appear on specific days of the cycle? Do benefits compound over multiple cycles, or do they remain constant?
This data becomes particularly valuable if you later decide to modify your protocol or try a different schedule. Understanding your baseline response to the Fadiman protocol gives you a reference point for evaluating alternatives.
Paul Stamets, the renowned mycologist whose work spans decades of fungal research, proposed a microdosing protocol that differs significantly from Fadiman’s approach. Where Fadiman emphasizes simplicity and minimal intervention, Stamets advocates for a more aggressive schedule combined with synergistic compounds designed to amplify neuroplastic effects.
Stamets’ protocol reflects his broader philosophy about the relationship between humans and fungi. He views psilocybin not as a drug to be used cautiously, but as a natural compound that humans have co-evolved with and that may play important roles in cognitive enhancement and neurological health. This perspective informs his more intensive approach to scheduling.
The Stamets stack has gained particular popularity among people interested in cognitive enhancement, neuroprotection, and long-term brain health. Its combination of multiple compounds appeals to those who want to maximize potential benefits rather than simply test whether microdosing affects them at all.
The Stamets protocol calls for four consecutive dosing days followed by three rest days, creating a weekly rhythm that many people find easy to remember. Dose Monday through Thursday, rest Friday through Sunday, repeat. This schedule results in significantly more dosing days per month than the Fadiman protocol, roughly 16 compared to 10.
This more intensive approach rests on different assumptions about tolerance and neuroplasticity. Stamets believes that consecutive dosing days may produce cumulative effects that single isolated doses cannot achieve, particularly when combined with the other compounds in his stack. The three rest days then allow tolerance to reset before the next cycle begins.
Critics of this approach worry about the higher frequency of dosing and the potential for tolerance to build within the four-day dosing window. Some practitioners report diminishing effects by day three or four of the cycle, suggesting that tolerance may indeed be a factor. Others find that the consecutive days produce a sustained shift in baseline functioning that they prefer to the more punctuated effects of the Fadiman protocol.
The weekly rhythm has practical advantages for people with regular work schedules. Knowing that you’ll always dose on the same four days each week makes planning easier and reduces the cognitive load of tracking where you are in your cycle. The weekend rest days also mean you’re at baseline during social activities and family time, which some people prefer.
The distinctive feature of the Stamets stack is its combination of three compounds: psilocybin mushrooms, Lion’s Mane mushroom extract, and niacin (vitamin B3). Each component serves a specific purpose in Stamets’ theory of synergistic neuroplasticity.
Psilocybin provides the primary psychoactive effect, promoting neuroplasticity and potentially stimulating neurogenesis through its action on serotonin receptors. Lion’s Mane contains compounds called hericenones and erinacines that have demonstrated nerve growth factor stimulation in laboratory studies. Niacin causes vasodilation, the flushing sensation familiar to anyone who’s taken high-dose B3, which Stamets theorizes helps distribute the other compounds throughout the peripheral nervous system.
Typical dosing for the stack involves 0.1 to 0.3 grams of psilocybin mushrooms, 500 to 1000 milligrams of Lion’s Mane extract, and 100 to 200 milligrams of niacin. The niacin dose is intentionally high enough to produce a mild flush, which some people find uncomfortable but which Stamets considers essential to the protocol’s effectiveness.
The scientific evidence for this specific combination remains limited. Lion’s Mane has promising research behind it for cognitive support and nerve health, but most studies have been conducted in isolation rather than in combination with psilocybin. The niacin component is more speculative, based on theoretical mechanisms rather than direct evidence. Still, many practitioners report subjectively positive experiences with the full stack.
One practical consideration: the niacin flush can be intense for people who aren’t accustomed to it. Starting with a lower niacin dose and gradually increasing allows your body to adapt. Some people never become comfortable with the flush and choose to use the stack without niacin or substitute non-flushing niacin forms, though Stamets specifically recommends the flushing variety.
Not everyone thrives on rigid schedules. Some people find that predetermined protocols feel constraining or don’t align with the natural rhythms of their lives. Alternative approaches range from modified versions of the standard protocols to fully intuitive dosing based on real-time self-assessment.
These alternatives often appeal to experienced microdosers who have already spent time with structured protocols and developed enough self-awareness to recognize when they might benefit from a dose versus when they should abstain. They also suit people whose schedules are highly variable or who prefer a more organic relationship with their practice.
The trade-off with less structured approaches is reduced consistency and potentially less reliable data about what’s actually working. If you’re dosing whenever you feel like it, it becomes harder to distinguish between substance effects and normal fluctuations in mood and cognition. For this reason, most practitioners recommend starting with a structured protocol before transitioning to more intuitive methods.
While most microdosing protocols emphasize morning dosing, the nightcap approach flips this convention entirely. Practitioners take their microdose in the evening, typically one to two hours before bed, using the subtle psychoactive effects to enhance dream vividness, facilitate emotional processing during sleep, and promote reflection.
This protocol appeals to people who find that morning microdoses interfere with their work focus or who want to separate their microdosing practice from their productive hours. Some report that evening dosing produces more pronounced effects on mood and emotional well-being the following day, possibly because the substance is active during sleep when the brain consolidates memories and processes emotional experiences.
The nightcap approach does carry risks that daytime dosing doesn’t. Some people find that any psychoactive substance, even at sub-perceptual doses, interferes with sleep quality. Others report increased dream intensity that borders on uncomfortable. Starting with very low doses and carefully monitoring sleep quality helps identify whether this approach works for you.
Scheduling for the nightcap protocol can follow any of the standard patterns: Fadiman’s one-on-two-off, Stamets’ four-on-three-off, or alternatives. The timing shift doesn’t change the underlying logic of rest days and tolerance management.
The every-other-day protocol represents a middle ground between Fadiman’s conservative approach and Stamets’ more intensive schedule. Dosing every other day results in roughly 15 doses per month, similar to the Stamets stack but without the consecutive dosing days.
Proponents of this approach argue that it maximizes the benefits of regular dosing while still providing daily rest periods for tolerance management. The alternating rhythm is also easy to remember: if you dosed yesterday, you don’t dose today. No counting days or tracking cycles required.
Fixed weekday schedules take a different approach entirely, choosing specific days of the week for dosing regardless of how they fall in relation to each other. Someone might dose every Monday and Thursday, for example, creating a consistent rhythm that aligns with their work week. This approach prioritizes predictability and schedule integration over optimal spacing.
The Monday-Thursday pattern is popular because it spaces doses roughly three days apart while ensuring you’re at baseline for weekends. Tuesday-Friday or Wednesday-Saturday variations work for people with different schedule preferences. The key is consistency: picking your days and sticking with them long enough to evaluate the effects.
Intuitive dosing abandons predetermined schedules entirely in favor of real-time self-assessment. You dose when you feel it would be beneficial and abstain when you don’t. This approach requires significant self-knowledge and honest self-evaluation to work well.
The transition to intuitive dosing typically happens after months of structured practice. During that time, you learn to recognize the subtle signs that indicate you might benefit from a dose: low mood, creative blocks, rumination patterns, or simply a sense that something is slightly off. You also learn to recognize when dosing wouldn’t serve you: high-stress situations where you need maximum stability, days when you’re already feeling great, or periods when you sense you need integration time.
Intuitive dosers often find that their natural rhythm settles into something resembling a loose schedule anyway, perhaps dosing two to three times per week on average but with flexibility to adjust based on circumstances. The difference is that the schedule emerges from internal awareness rather than external rules.
The risk with intuitive dosing is self-deception. It’s easy to convince yourself you “need” a dose when you’re actually just seeking the pleasant effects, or to avoid dosing when you’re anxious about something unrelated to the practice itself. Maintaining honesty with yourself, perhaps through journaling or regular check-ins with a trusted friend, helps keep intuitive dosing grounded in genuine self-awareness rather than rationalized desire.
Choosing a schedule is just the beginning. Long-term success with microdosing depends on how you engage with the practice beyond simply taking the substance on the right days. The people who report the most significant and lasting benefits tend to approach microdosing as one component of a broader commitment to personal development rather than as a standalone intervention.
This doesn’t mean you need to overhaul your entire life to microdose effectively. But it does mean paying attention to the context surrounding your practice: your intentions, your observations, your integration of insights, and your willingness to take breaks when needed.
The most common mistake people make is treating microdosing like a pharmaceutical, something you take passively and expect to work automatically. The practice seems to work better when approached more actively, with curiosity about what you’re experiencing and willingness to act on whatever insights emerge.
Keeping a microdosing journal serves multiple purposes. It creates a record you can review to identify patterns over time. It forces you to pay attention to your experience in ways you might otherwise skip. And the act of writing itself can help clarify thoughts and feelings that might otherwise remain vague.
Your journal doesn’t need to be elaborate. Simple daily notes covering mood, energy, focus, sleep quality, and any notable experiences provide enough data to track trends. Some people add specific metrics they’re trying to improve: anxiety levels, creative output, social comfort, or whatever drew them to microdosing in the first place.
Intentionality means approaching each dose with some sense of purpose. This doesn’t require elaborate rituals or spiritual framing, though some people find those meaningful. It can be as simple as taking a moment before dosing to reflect on what you hope to gain from the practice or what you want to pay attention to that day.
Setting intentions seems to amplify the benefits of microdosing for many practitioners. The substance may open windows of neuroplasticity, but intention helps direct where that plasticity goes. If you’re microdosing to reduce anxiety, holding that intention may help your brain prioritize changes that serve that goal. If you’re seeking creative enhancement, intention points your attention toward creative opportunities you might otherwise miss.
Every serious microdosing protocol includes recommendations for periodic breaks, typically suggesting four to six weeks of dosing followed by two to four weeks off. These integration periods serve purposes that go beyond simple tolerance management.
Extended breaks allow you to evaluate what, if anything, has actually changed. When you’re dosing regularly, it’s hard to distinguish between direct substance effects and lasting shifts in your baseline functioning. Taking time off reveals which benefits persist without ongoing dosing and which were dependent on the substance itself.
Integration periods also provide space for psychological processing. Microdosing, even at sub-perceptual levels, may surface emotional material or shift perspectives in ways that benefit from reflection. Time away from the practice allows you to work with whatever has emerged without the ongoing influence of additional doses.
Some practitioners find that their relationship with microdosing changes after integration periods. They may return to the practice with renewed appreciation, or they may discover that they no longer feel drawn to it in the same way. Both outcomes are valid. The goal isn’t to microdose forever but to use the practice in service of your broader well-being and development.
The specific length of your integration periods can vary based on how long you’ve been dosing and what feels right for you. Someone who has completed one month of the Fadiman protocol might take two weeks off before deciding whether to continue. Someone who has been dosing for six months might benefit from a full month away. Listen to your intuition, but err on the side of longer breaks rather than shorter ones.
Finding the right microdosing schedule requires patience, self-honesty, and willingness to experiment. Start with a structured protocol, track your experience carefully, and adjust based on what you learn about yourself. The protocols outlined here, from Fadiman’s conservative approach to Stamets’ synergistic stack to various intuitive methods, offer proven frameworks that have worked for thousands of people. Your task is discovering which framework, or which combination of elements from multiple frameworks, works for you. The schedule that produces the best results is always the one you can maintain consistently while remaining attentive to what the practice is teaching you about yourself.